| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/09537104.2016.1227062 |
| P698 | PubMed publication ID | 27753514 |
| P50 | author | Madhumita Chatterjee | Q64858095 |
| P2093 | author name string | Meinrad Gawaz | |
| P2860 | cites work | Evolutionary divergence and functions of the ADAM and ADAMTS gene families | Q21245456 |
| Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor | Q24321786 | ||
| A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion | Q24621493 | ||
| Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain | Q28145083 | ||
| The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors | Q28145360 | ||
| Platelet-collagen interaction: is GPVI the central receptor? | Q28185377 | ||
| Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice | Q28267720 | ||
| Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans | Q28278222 | ||
| The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times | Q28535276 | ||
| Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis | Q30455730 | ||
| Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets | Q33349386 | ||
| The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats | Q33374356 | ||
| Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa | Q33376631 | ||
| A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex | Q33379144 | ||
| Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. | Q33379632 | ||
| Measuring soluble platelet glycoprotein VI in human plasma by ELISA. | Q33384477 | ||
| Proteolysis of platelet receptors in humans and other species | Q33389665 | ||
| Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin. | Q50554991 | ||
| Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. | Q50970470 | ||
| The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice. | Q51757699 | ||
| An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis. | Q51778345 | ||
| Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding. | Q51806436 | ||
| Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). | Q51841836 | ||
| The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion | Q52550457 | ||
| High-frequency ultrasound-guided disruption of glycoprotein VI-targeted microbubbles targets atheroprogressison in mice. | Q52654271 | ||
| Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using (64)Cu-labeled glycoprotein VI-Fc. | Q53092873 | ||
| Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. | Q53311584 | ||
| Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain. | Q54695208 | ||
| Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous. | Q54698739 | ||
| Soluble Glycoprotein VI Is Raised in the Plasma of Patients With Acute Ischemic Stroke | Q57306100 | ||
| Sandwich Immunoassay for Soluble Glycoprotein VI in Patients with Symptomatic Coronary Artery Disease | Q57735718 | ||
| Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels | Q59281453 | ||
| Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa | Q59281458 | ||
| Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura | Q59281467 | ||
| Ligand Binding Rapidly Induces Disulfide-dependent Dimerization of Glycoprotein VI on the Platelet Plasma Membrane | Q59281484 | ||
| Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. | Q33414254 | ||
| Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro | Q33475093 | ||
| Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease | Q33870879 | ||
| A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents. | Q34124802 | ||
| The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways | Q34368551 | ||
| The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke | Q34917692 | ||
| Platelets in atherothrombosis | Q34986345 | ||
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. | Q35558849 | ||
| The role of collagen in thrombosis and hemostasis | Q35752946 | ||
| Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. | Q35848605 | ||
| Snake venom probes of platelet adhesion receptors and their ligands | Q36143048 | ||
| Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood | Q36215984 | ||
| Role of calmodulin in platelet receptor function | Q36297698 | ||
| Platelets in inflammation and atherogenesis. | Q36328825 | ||
| Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice | Q36376147 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Platelets as immune cells: bridging inflammation and cardiovascular disease | Q36699744 | ||
| Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity | Q36803375 | ||
| Radionuclide imaging: a molecular key to the atherosclerotic plaque | Q37196226 | ||
| Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'. | Q37289019 | ||
| Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties | Q37466636 | ||
| Diagnostic and therapeutic potentials of platelet glycoprotein VI. | Q37736347 | ||
| Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke | Q37903934 | ||
| Platelet GPVI: a target for antithrombotic therapy?! | Q38035484 | ||
| The future of glycoprotein VI as an antithrombotic target. | Q38047358 | ||
| Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease | Q39912642 | ||
| Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. | Q40143775 | ||
| Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease | Q40174296 | ||
| Coronary Plaque Disruption | Q40459835 | ||
| Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells | Q40531263 | ||
| The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion | Q40766523 | ||
| A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. | Q40807170 | ||
| Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke | Q43290763 | ||
| Ex vivoimaging of injured arteries in rabbits using fluorescence-labelled glycoprotein VI-Fc | Q44156689 | ||
| Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome | Q44203026 | ||
| An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families | Q44209400 | ||
| Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase | Q45016543 | ||
| Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo | Q45042577 | ||
| Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo | Q45764285 | ||
| The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice | Q46530171 | ||
| Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation | Q48186665 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 362-371 | |
| P577 | publication date | 2016-10-18 | |
| P1433 | published in | Platelets | Q1573582 |
| P1476 | title | Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool | |
| P478 | volume | 28 |
| Q64263252 | A novel anti-platelet aggregation target of chinensinaphthol methyl ether and neojusticin B obtained from Rostellularia procumbens (L.) Nees |
| Q98945656 | Collagen-dependent platelet dysfunction and its relevance to either mitochondrial ROS or cytosolic superoxide generation: a question about the quality and functional competence of long-stored platelets |
| Q89820694 | Imaging Platelet Processes and Function-Current and Emerging Approaches for Imaging in vitro and in vivo |
| Q50002204 | Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. |
| Q59281355 | Proteolytic processing of platelet receptors |
| Q48273240 | The cutting edge of platelets |
Search more.